Press Release: Reunion raises over $100M to build a better psychedelic drug

The funding will help Reunion pay for a mid-stage clinical trial testing its most advanced medicine — essentially a synthetic version of psilocin — in women with postpartum depression. Reunion Neuroscience, a drug company developing psychedelics for the treatment of mental health conditions, has raised tens of millions of dollars to support its research efforts. […]